FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015385940> ?p ?o ?g. }

• W2015385940 endingPage "1180" @default.
• W2015385940 startingPage "1171" @default.
• W2015385940 abstract "Effective treatments for malignant neuroendocrine tumors are under development. While iodine-131 metaiodobenzylguanidine (131I-MIBG) radiotherapy has been used in the treatment of malignant neuroendocrine tumors, there are few studies evaluating its therapeutic effects and safety in a multicenter cohort. In the current study, we sought to evaluate the effects and safety of 131I-MIBG therapy for conditions including malignant pheochromocytoma and paraganglioma within a multicenter cohort. Forty-eight malignant neuroendocrine tumors (37 pheochromocytoma and 11 paraganglioma) from four centers underwent clinical 131I-MIBG radiotherapy. The tumor responses were observed before and 3 to 6 months after the 131I-MIBG radiotherapy in accordance with RECIST criteria. We also evaluated the data for any adverse effects. The four centers performed a total of 87 131I-MIBG treatments on 48 patients between January 2000 and March 2009. Of the treatments, 65 were evaluable using RECIST criteria. One partial response (PR), 40 stable disease (SD), and 9 progressive disease (PD) in malignant pheochromocytoma were observed after each treatment. Fourteen SD and one PD-were observed in paraganglioma. Patients with normal hypertension (systolic blood pressure (BP) > 130 mmHg) showed significantly reduced systolic BP after the initial follow-up (n=10, 138.1±8.2 to 129.5±13.5 mmHg, P=0.03). In adult neuroendocrine tumors with a treatment-basis analysis, there were side effects following 41 treatments (47.1%) and most of them (90.2%) were minor. In this multicenter registry, PR or SD was achieved in 84.6% of the treatment occasions in adult neuroendocrine tumors through 131I-MIBG radiotherapy. This indicated that most of the 131I-MIBG radiotherapy was performed safely without significant side effects." @default.
• W2015385940 created "2016-06-24" @default.
• W2015385940 creator A5000472447 @default.
• W2015385940 creator A5000743681 @default.
• W2015385940 creator A5014031939 @default.
• W2015385940 creator A5018227162 @default.
• W2015385940 creator A5021226320 @default.
• W2015385940 creator A5023695419 @default.
• W2015385940 creator A5030091429 @default.
• W2015385940 creator A5034452868 @default.
• W2015385940 creator A5053721196 @default.
• W2015385940 creator A5054069029 @default.
• W2015385940 creator A5054271905 @default.
• W2015385940 creator A5071379692 @default.
• W2015385940 creator A5073481906 @default.
• W2015385940 creator A5076772805 @default.
• W2015385940 creator A5079561204 @default.
• W2015385940 creator A5090705147 @default.
• W2015385940 date "2014-01-01" @default.
• W2015385940 modified "2023-10-16" @default.
• W2015385940 title "Effects and safety of 131I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: Results from a multicenter observational registry" @default.
• W2015385940 cites W1966893598 @default.
• W2015385940 cites W2011891156 @default.
• W2015385940 cites W2013342327 @default.
• W2015385940 cites W2022755629 @default.
• W2015385940 cites W2029563033 @default.
• W2015385940 cites W2037479586 @default.
• W2015385940 cites W2038439665 @default.
• W2015385940 cites W2041573853 @default.
• W2015385940 cites W2042750219 @default.
• W2015385940 cites W2055454912 @default.
• W2015385940 cites W2060218822 @default.
• W2015385940 cites W2068511808 @default.
• W2015385940 cites W2095058352 @default.
• W2015385940 cites W2115884349 @default.
• W2015385940 cites W2127775057 @default.
• W2015385940 cites W2131438124 @default.
• W2015385940 cites W2136412998 @default.
• W2015385940 cites W2139248078 @default.
• W2015385940 cites W2142351970 @default.
• W2015385940 cites W2143973920 @default.
• W2015385940 cites W2144445356 @default.
• W2015385940 cites W2153367841 @default.
• W2015385940 cites W2156121263 @default.
• W2015385940 cites W2158466122 @default.
• W2015385940 cites W2165205961 @default.
• W2015385940 cites W2167466716 @default.
• W2015385940 cites W2917732217 @default.
• W2015385940 cites W4210969235 @default.
• W2015385940 cites W4211031423 @default.
• W2015385940 cites W4247222934 @default.
• W2015385940 cites W2005547168 @default.
• W2015385940 doi "https://doi.org/10.1507/endocrj.ej14-0211" @default.
• W2015385940 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25214026" @default.
• W2015385940 hasPublicationYear "2014" @default.
• W2015385940 type Work @default.
• W2015385940 sameAs 2015385940 @default.
• W2015385940 citedByCount "41" @default.
• W2015385940 countsByYear W20153859402015 @default.
• W2015385940 countsByYear W20153859402016 @default.
• W2015385940 countsByYear W20153859402017 @default.
• W2015385940 countsByYear W20153859402018 @default.
• W2015385940 countsByYear W20153859402019 @default.
• W2015385940 countsByYear W20153859402020 @default.
• W2015385940 countsByYear W20153859402021 @default.
• W2015385940 countsByYear W20153859402022 @default.
• W2015385940 countsByYear W20153859402023 @default.
• W2015385940 crossrefType "journal-article" @default.
• W2015385940 hasAuthorship W2015385940A5000472447 @default.
• W2015385940 hasAuthorship W2015385940A5000743681 @default.
• W2015385940 hasAuthorship W2015385940A5014031939 @default.
• W2015385940 hasAuthorship W2015385940A5018227162 @default.
• W2015385940 hasAuthorship W2015385940A5021226320 @default.
• W2015385940 hasAuthorship W2015385940A5023695419 @default.
• W2015385940 hasAuthorship W2015385940A5030091429 @default.
• W2015385940 hasAuthorship W2015385940A5034452868 @default.
• W2015385940 hasAuthorship W2015385940A5053721196 @default.
• W2015385940 hasAuthorship W2015385940A5054069029 @default.
• W2015385940 hasAuthorship W2015385940A5054271905 @default.
• W2015385940 hasAuthorship W2015385940A5071379692 @default.
• W2015385940 hasAuthorship W2015385940A5073481906 @default.
• W2015385940 hasAuthorship W2015385940A5076772805 @default.
• W2015385940 hasAuthorship W2015385940A5079561204 @default.
• W2015385940 hasAuthorship W2015385940A5090705147 @default.
• W2015385940 hasBestOaLocation W20153859401 @default.
• W2015385940 hasConcept C126322002 @default.
• W2015385940 hasConcept C126838900 @default.
• W2015385940 hasConcept C126894567 @default.
• W2015385940 hasConcept C143998085 @default.
• W2015385940 hasConcept C168563851 @default.
• W2015385940 hasConcept C197934379 @default.
• W2015385940 hasConcept C2776734335 @default.
• W2015385940 hasConcept C2779066768 @default.
• W2015385940 hasConcept C2779512018 @default.
• W2015385940 hasConcept C2992435398 @default.
• W2015385940 hasConcept C509974204 @default.
• W2015385940 hasConcept C71924100 @default.
• W2015385940 hasConcept C72563966 @default.

• next